Business & Finance
Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline
17 April 2024 - Germany-based pharmaceutical company Boehringer Ingelheim announced on Tuesday a strong acceleration of its pipeline in 2023, as pivotal trials in key research areas progressed as plan...
AstraZeneca increases dividend by 7%
11 April 2024 - Biopharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (Nasdaq:AZN) announced on Thursday a 7% increase in its annualised dividend for 2024, raising it by USD0.20 to USD3.10 per...
Rockwell Medical expands distribution in Dominican Republic and Bermuda, targets USD1m annual revenue boost
4 April 2024 - Healthcare company Rockwell Medical Inc (Nasdaq:RMTI) announced on Thursday that it has signed new distribution agreements with BioNuclear and Atlantic Medical International (AMI) in th...
Poolbeg PHarma plc receives notice of allowance for POLB 001 patent
20 March 2024 - Biopharmaceutical company Poolbeg Pharma (AIM: POLB) (OTCQB: POLBF) announced on Wednesday that it has been granted a Notice of Allowance from the US Patent Office for its Immunomodula...
Wolters Kluwer enhances Clinical GenAI leadership with AI Labs powered by UpToDate
11 March 2024 - Healthcare technology company Wolters Kluwer Health (EURONEXT: WKL) announced on Monday that it has achieved significant milestones with AI Labs, the Clinical Generative AI (GenAI) bet...
Amgen announces share dividend for Q2 2024
7 March 2024 - Amgen (NASDAQ:AMGN), a United States-based biopharmaceutical company, announced on Wednesday its share dividend for the second quarter of 2024.The company has declared share dividend of...